SOP 220 – Investigation of allegations of Research Fraud and Misconduct SOP 220 v2
Preview
Overview
The purpose of this SOP is to ensure that NNUH and UEA fulfil their requirements to identify and manage all reports of suspected fraud and misconduct appropriately in accordance with UK law and the UK Policy Framework for Health and Social Care Research. Equally its aim is to create an environment where equal emphasis is placed on accountability and learning and to ensure there is a mechanism to raise concerns without fear of reprisals and respond with a compassionate approach to reviewing issues involving potential misconduct.
NNUH and UEA value the importance of producing high quality and safe research and rely on the personal and scientific integrity of individuals involved in research. Research misconduct is contrary to this value places participants at risk and erodes confidence in the scientific integrity of research as a whole and jeopardies the reputation of NNUH / UEA and their employees.
Categories
ClinicalReference
Date Uploaded
14.02.2024Date Review
08.01.2027File Size
629KbClinical Guidelines
This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.